Imprinting disorders
Gene: L3MBTL1
Germline variation in this imprinted gene is not currently associated with disease.
Somatic deletions of 20q are associated with chronic myeloid malignancies. Aziz et al showed that a single heterozygous 20q deletion consistently resulted in the complete loss of expression of the imprinted genes L3MBTL1 and SGK2, indicative of a pathogenetic role for loss of the active paternally inherited locus. Concomitant loss of both L3MBTL1 and SGK2 dysregulated erythropoiesis and megakaryopoiesis.Created: 15 Oct 2021, 3:18 a.m. | Last Modified: 15 Oct 2021, 3:18 a.m.
Panel Version: 0.13
Publications
Gene: l3mbtl1 has been classified as Red List (Low Evidence).
Publications for gene: L3MBTL1 were set to http://igc.otago.ac.nz/home.html; 23543057; PMID: 15123827; 30794780
Gene: l3mbtl1 has been classified as Red List (Low Evidence).
gene: L3MBTL1 was added gene: L3MBTL1 was added to Imprinting disorders. Sources: Expert Review Green,Genomics England PanelApp Mode of inheritance for gene: L3MBTL1 was set to MONOALLELIC, autosomal or pseudoautosomal, maternally imprinted (paternal allele expressed) Publications for gene: L3MBTL1 were set to http://igc.otago.ac.nz/home.html; 23543057; PMID: 15123827; 30794780 Phenotypes for gene: L3MBTL1 were set to Affected tissue: myeloid lineages; Phenotype resulting from under expression: lymphoid malignancy